NASDAQ · SOPH
SOPHiA GENETICS SA
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SOPH: Nov 03, 2026
SOPHiA GENETICS SA Ordinary Shares is expected to report earnings on 11/03/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.13. The reported EPS for the same quarter last year was $-0.3.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Dec 2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Mar 2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Jun 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · MarketBeat · The Motley Fool- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
- RTTNews · Oct 8, 10:50 AM EDTMyriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGIS(RTTNews) – Myriad Genetics (MYGN) and SOPHiA GENETICS (SOPH) announced a collaboration with AstraZeneca (AZN) to advance a new prostate cancer-specific genomic instability score, or PrGIS, for precision oncology.
- RTTNews · Oct 8, 9:29 AM EDTSOPHiA GENETICS Partners Myriad Genetics To Advance Prostate Genomic Instability Score Technology(RTTNews) – SOPHiA GENETICS (SOPH) and Myriad Genetics, Inc. (MYGN) announced Thursday a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (AZN).
- Zacks · Sep 18, 6:48 AM EDTSOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- MarketBeat · Aug 27, 8:35 AM EDTWhen Unusual Volume Isn't Noise: 3 Small-Caps Sending SignalsThe volume of shares traded in a session often gets a passing mention in the financial press until a stock experiences unusually high volume. That's because volume can provide an important measure of the conviction behind a stock's price movement. Stocks that trade at a multiple
- RTTNews · Aug 20, 4:21 AM EDTBiotech Stocks At 52-Week Highs – MRNA Surges +176% On Phase 3 Data, SCTV, MRVI, SOPH, IMNM(RTTNews) – The following biotech stocks reached a 52-week high on August 19, 2026, primarily driven by positive clinical research results and promising quarterly reports.
- The Motley Fool · Aug 11, 12:46 PM EDTSOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 5, 4:09 AM EDTBiotech Stocks At 52-Week Highs – UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS(RTTNews) – The following biotech stocks reached a 52-week high on August 4, 2026, driven by key catalysts like positive quarterly results or certain regulatory milestones.
- MarketBeat · Aug 4, 2:04 PM EDTSOPHiA GENETICS Q2 Earnings Call HighlightsSOPHiA GENETICS (NASDAQ:SOPH) reported second-quarter revenue growth of 27% and raised its full-year revenue outlook, as the precision medicine software company cited accelerating U.S. adoption, liquid biopsy momentum and new biopharma agreements. Revenue for the second quarter
- Zacks · Jul 24, 11:03 AM EDTTempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?TEM heads into Q2 earnings with 21.3% expected revenue growth, strong diagnostics demand and AI deals, but near-term margin pressure remains.
- RTTNews · Jul 21, 3:41 AM EDTBiotech Stocks At 52-Week Highs – XNCR, COAG, MNPR, SOPH, ACRS(RTTNews) – The following biotech stocks reached a 52-week high on July 20, 2026, driven by key catalysts such as upcoming clinical trial launches and the prospective release of data from these studies.
- RTTNews · Jun 22, 2:57 AM EDTSOPHiA Genetics Closes Public Offering Of $57 Mln Of Shares(RTTNews) – SOPHiA GENETICS SA (SOPH), a cloud-native healthcare technology, on Friday said it closed a $57 million public offering of shares announced on June 16.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for SOPHiA GENETICS SA from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.